Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing
IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11